mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.022 |
0.7 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |